Stock comparison
Biogen
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BIIB
Biogen
Market cap
$28.61B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BIIB | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 53C | 69B | MTD |
| Benjamin Graham | 63C | 65B | MTD |
| Philip Fisher | 43D | 63C | MTD |
| Peter Lynch | 21F | 66B | MTD |
| Joel Greenblatt | 34F | 68B | MTD |
| Charlie Munger | 48D | 74B | MTD |
| Terry Smith | 49D | 70B | MTD |
Side-by-side metrics
| Metric | BIIB | MTD |
|---|---|---|
| Market cap | $28.61B | $22.29B |
| P/E (TTM) | 21.2x | 25.3x |
| EV/EBIT | 17.3x | 21.6x |
| ROIC (TTM) | 5.44% | 36.09% |
| Gross margin | 69.77% | 57.79% |
| Net margin | 13.92% | 21.4% |
| Revenue CAGR 5y | -2.78% | 2.01% |
| EPS CAGR 5y | -4.05% | 6.12% |
| Debt / Equity | 0.4x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BIIB leads on
- Market cap$28.61Bvs $22.29B+22%
- EV/EBIT17.3xvs 21.6x+20%
- Gross margin69.77%vs 57.79%+17%
- P/E (TTM)21.2xvs 25.3x+16%
MTD leads on
- Revenue CAGR 5y2.01%vs -2.78%+172%
- EPS CAGR 5y6.12%vs -4.05%+166%
- Debt / Equity-vs 0.4x+101%
- ROIC (TTM)36.09%vs 5.44%+85%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.